You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
亞太藥業(002370.SZ):2020年度業績扭虧為盈至2727.5萬元
格隆匯 03-26 19:46

格隆匯3月26日丨亞太藥業(002370.SZ)披露2020年年度報吿,實現營業收入5.15億元,同比下降27.41%;歸屬於上市公司股東的淨利潤2727.5萬元,上年同期虧損19.4億元(調整後);歸屬於上市公司股東的扣除非經常性損益的淨虧損1.43億元,上年同期虧損19.4億元(調整後);基本每股收益0.05元。

2020年度,面對新冠肺炎疫情及複雜多變的國內外形勢,公司上下共同努力,在做好疫情防控的同時,積極組織復工復產,最大限度減少疫情對公司經營帶來的不利影響。公司持續專注醫藥製造業,堅持研發創新為導向,不斷優化產品管線,加大市場開拓力度,合理安排和使用資金,確保公司穩定發展。公司本期業績實現扭虧為盈,主要系公司柯橋廠區房屋拆遷補償所致。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account